Comparison of plasma lipid and lipoprotein profiles in hypertensive black versus white men

American Journal of Cardiology

Volumn 78, Issue 11, 1996, Pages 1236-1241

  Lakshman, M Raj ^a,b   Reda, Domenic ^a   Materson, Barry J ^a   Cushman, William C ^a   Kochar, Mahendr S ^a   Nunn, Stewart ^a   Hamburger, Robert J ^a   Freis, Edward D ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RENIN;

ARTICLE; BLOOD; CAUCASIAN; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; HUMAN; HYPERTENSION; MALE; NEGRO; REGRESSION ANALYSIS; RISK FACTOR;

AFRICAN CONTINENTAL ANCESTRY GROUP; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; REGRESSION ANALYSIS; RENIN; RISK FACTORS;

EID: 0030329892     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00602-9     Document Type: Article

References (30)

1. Weidmann P, Uehlinger DE, Gerber A. Antihypertensive treatment and serum lipoproteine. J Hypertens 1985;3:297-306.
2. Ross, R. The pathology of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
3. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet 1986;2:933-936.
4. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: multiple risk factor changes and mortality results. JAMA 1982;248:1465-1477.
5. The Lipid Research Clinic Coronary Primary Prevention Trial Results: Reduction in the incidence of coronary heart disease: Lipid Research Clinic Program. JAMA 1984;251:351-364.
6. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. Highdensity lipoprotein as a protective factor against coronary heart disease: The Framingham Study. Am J Med 1977;62:707-714.
7. Castelli WP, Garrison RJ Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels; The Framingham Study. JAMA 1986;256:2835-2838.
8. Livshits G, Weisbort J, Meshulam N, Brunner D. Multivariate analysis of the twenty-year follow-up of the Donolo-Tel Aviv prospective coronary artery disease study and the usefulness of HDL cholesterol percentage. Am J Cardiol 1989;63:676-681.
9. Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJ. Apolipoprotein A-I as a marker of angiographically associated coronary-artery disease. N Engl J Med 1983;309:385-389.
10. Albers JJ, Brunzell JD, Knoop RH; Apoprotein measurements and their clinical applications. Clinics in Lab Med 1989:9:137-152.
11. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman MR, Gottdiener J, Ramirez EA, Henderson WG. Single-drug therapy for hypertension in men: a comparison of six anti-hypertensive agents with placebo. N Engl J Med 1993;328:914-921.
12. Gidez LI, Miller GJ, Burstein M, Eder HA. Analysis of plasma high density lipoprotein subclasses by a precipitation procedure: correlation with preparative and analytical ultracentrifugation. In: Report of High Density Lipoprotein Methodology Workshop. Section V, Part 28 (NIH publication no. 79-1661). Bethesda, Md.: US Dept. of Health and Human Services 1984:328-342.
13. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasmas without the use of preparative ultracentrifuge. Clin Chem 1972;18:499-508.
14. Lopez-Virella MF, Virella G. Immunonephelometric determination of apolipoproteins. In: Lippel K, ed. Proceedings of the Workshop on Apoprotein Quantification. Bethesda, MD: National Institutes of Health 1983;289-313.
15. 1. J Lab Clin Med 1989;113:632-641.
16. Hamburger RJ, Flamenbaum W. Renin angiotensin axis. In: Breslin DJ, ed. Renovascular Hypertension. Baltimore: Williams & Wilkins 1982:1-29.
17. SAS Institute. SAS/STAT User's Guide, Version 6, 4th ed. vols. 1, 2. Cary, NC: SAS Institute Inc.
18. Rifkind BM, Segal P. Lipid Research Clinic program reference values for hyperlipidemia and hypolipidemia. JAMA 1983;250:1869-1872.
19. Hulley SB, Gordon S. Alcohol and high-density lipoprotein cholesterol. Causal inference from diverse study designs. Circulation 1981;64(suppl III):III-57-III-63.
20. Puddey IB, Masarei JRL, Vandongen R, Beilin LJ. Serum apolipoprotein A-II as a marker of change in alcohol intake in male drinkers. Br J Alc Alcohol 1986;21:375-383.
21. Hartung GH, Foreyt JP, Mitchell RE, Reeves RS Gotto AM. Effect of alcohol intake on high density lipoprotein cholesterol levels in runners and inactive men. JAMA 1983;249:747-750.
22. Haskell WL, Camargo C Jr, Williams PT, Vranizan KM, Krauss RM, Lindgren FT, Wood PD. The effect of cessation and resumption of moderate alcohol intake on serum high-density lipoprotein subfractions. A controlled study. N Engl J Med 1984;310:805-810.
23. Cushman P, Barboriak J, Kalbfleisch J. Alcohol, high density lipoproteins, apolipoproteins. Alcoholism Clin Exp Res 1986;10:154-157.
24. Castelli WP. The triglyceride issue: a view from Framingham. Am Heart J 1986;112:432-440.
25. Austin MA. Plasma triglyceride as a risk factor for coronary heart disease: the epidemiological evidence and beyond. Am J Epidemiol 1989:128:249-259.
26. Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease: Paris prospective study. Diabetes Care 1991;14:461-469.
27. Logan RL, Riemersma RA, Thomson M, Oliver MF, Olsson AG, Walldius G, Rossner S, Kaijser L, Callmer E, Carlson LA, Lockerbie L, Lutz W. Risk factors for ischemic heart disease in normal men aged 40: Edinburgh - Stock-holm study. Lancet 1978;1:949-955.
28. Reaven GM. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
29. Stout RW. Insulin and atheroma - 20 year perspective. Diabetes Care 1990;13:631-654.
30. Enas EA, Mehta JL. Malignant coronary artery disease in young Asian Indians:thoughts on pathogenesis, prevention and therapy. Clin Cardiol 1995;18:131-134.